Micro Emerging Active

Climb Bio'nun FDA Hızlı İntikal onayı

New narrative with limited coverage — still forming.

Puan
0,5
Hız
▲ 1,0
Makaleler
2
Kaynaklar
1

Sentiment Timeline

Event Timeline

Nis 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
Nis 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

İlgili Makaleler

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · Nis 24, 2026
Mixed

Zaman Çizelgesi

Son GüncellemeNis 22, 2026